FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

BENZODIAZEPINE ENZYME IMMUNOASSAY

K Number: K930529 · Decision Aug 5, 1993
Classifications
1
FEI Numbers
90
Registration Numbers
90
Same Product Code
89
Applicant Total
66
Review Days
184

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
BENZODIAZEPINE ENZYME IMMUNOASSAY
K Number
K930529
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
862.3170
Medical Specialty
Clinical Toxicology
Decision
Substantially Equivalent
Statement or Summary
Statement
Applicant
Diagnostic Reagents, Inc.
Date Received
February 2, 1993
Decision Date
August 5, 1993
Product Code
JXM
Advisory Committee
Clinical Toxicology
Review Advisory Committee
TX
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
JXM Enzyme Immunoassay, Benzodiazepine

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (JXM), ordered by most recent decision date.

View all

Other Clearances by Diagnostic Reagents, Inc.

K Number Device Name
K983268 MODIFICATION OF TRICYCLIC SERUM TOX EIA ASSAY
K983812 NAPA EIA ASSAY
K983323 DIGOXIN IMMUNOASSAY
K983280 VANCOMYCIN EIA ASSAY
K983159 DRUGS OF ABUSE URINE CALIBRATORS AND CONTROLS
K973102 LIDOCAINE EIA ASSAY
K972835 50NG/ML COCAINE METABOLITE CALIBRATOR
K972526 METHADONE EIA ASSAY
K964212 QUINIDINE ENZYME IMMUNOASSAY
K963835 DIGOXIN ENZYME IMMUNOASSAY
Search all 66 clearances from Diagnostic Reagents, Inc. →